Xiong, L., Lou, Y., Bai, H., Li, R., Xia, J., Fang, W., . . . Han, B. (2019). Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients. J Int Med Res.
Style de citation ChicagoXiong, Liwen, et al. "Efficacy of Erlotinib As Neoadjuvant Regimen in EGFR-mutant Locally Advanced Non-small Cell Lung Cancer Patients." J Int Med Res 2019.
Style de citation MLAXiong, Liwen, et al. "Efficacy of Erlotinib As Neoadjuvant Regimen in EGFR-mutant Locally Advanced Non-small Cell Lung Cancer Patients." J Int Med Res 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.